Medico Remedies Ltd. (IN:MEDICO)

:MEDICO

MEDICO

Medico Remedies Ltd.

RESEARCH TOOLSreports

Want to see IN:MEDICO full AI Analyst Report?

Medico Remedies Ltd. (MEDICO) Price & Analysis

0 Followers

MEDICO Stock Chart & Stats

₹50.16

₹4.58(8.10%)

At close: Jan 08 4:00 PM EST

₹50.16

₹4.58(8.10%)

Day’s Range― - ―

52-Week Range₹31.00 - ₹59.00

Previous CloseN/A

Volume2.72M

Average Volume (3M)12.74K

Market Cap

₹3.33B

Enterprise Value₹3.49B

Total Cash (Recent Filing)₹17.64M

Total Debt (Recent Filing)₹125.27M

Price to Earnings (P/E)36.5

Beta0.22

Next Earnings

May 30, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.35

Shares Outstanding82,984,000

10 Day Avg. Volume20,955

30 Day Avg. Volume12,740

Financial Highlights & Ratios

PEG Ratio1.99

Price to Book (P/B)7.06

Price to Sales (P/S)2.92

P/FCF Ratio258.26

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth & ProfitabilityConsistent revenue expansion and improving net margins indicate structural demand for the company’s products and growing profitability. Over 2-6 months this supports sustained cash generation, reinvestment capacity and resilience versus peers, underpinning long-term business stability.

Balance Sheet StrengthA solid equity base and prudent leverage provide financial flexibility to fund growth, absorb shocks and pursue strategic opportunities. Improving return on equity also signals more effective capital use, which supports durable shareholder value creation over the medium term.

Cash GenerationPositive FCF growth and strong operating-cash-to-net-income conversion show the business converts profits into cash, enabling capex funding, debt servicing and reinvestment. This durable cash generation underpins operational independence and longer-term strategic execution.

Bears Say

Volatile EBIT MarginLess stable EBIT margins point to variability in operating efficiency or cost structure, which weakens earnings predictability. Over months this can amplify earnings volatility, complicate planning for capex or R&D, and reduce visibility into sustainable profitability.

Capex Pressure On Free Cash FlowElevated capital expenditures reducing free-cash-flow conversion constrain liquidity for dividends, buybacks or debt reduction. If capex persists without proportional margin or revenue gains, it can limit financial flexibility and raise funding needs over the medium term.

Moderate Reliance On LiabilitiesA moderate reliance on liabilities increases refinancing and interest-rate sensitivity. While current leverage appears prudent, sustained dependence on liabilities could constrain strategic moves in downturns and requires active liability management to preserve long-term stability.

Medico Remedies Ltd. News

Medico Remedies Announces 31st AGM Details

Medico Remedies Ltd. ( ($IN:MEDICO) ) has provided an update. Medico Remedies Limited has announced the completion of...

9M ago

MEDICO FAQ

What was Medico Remedies Ltd.’s price range in the past 12 months?

Medico Remedies Ltd. lowest stock price was ₹31.00 and its highest was ₹59.00 in the past 12 months.

What is Medico Remedies Ltd.’s market cap?

Medico Remedies Ltd.’s market cap is ₹3.33B.

When is Medico Remedies Ltd.’s upcoming earnings report date?

Medico Remedies Ltd.’s upcoming earnings report date is May 30, 2026 which is in 30 days.

How were Medico Remedies Ltd.’s earnings last quarter?

Medico Remedies Ltd. released its earnings results on Feb 12, 2026. The company reported ₹0.346 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.346.

Is Medico Remedies Ltd. overvalued?

According to Wall Street analysts Medico Remedies Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medico Remedies Ltd. pay dividends?

Medico Remedies Ltd. does not currently pay dividends.

What is Medico Remedies Ltd.’s EPS estimate?

Medico Remedies Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medico Remedies Ltd. have?

Medico Remedies Ltd. has 82,984,000 shares outstanding.

What happened to Medico Remedies Ltd.’s price movement after its last earnings report?

Medico Remedies Ltd. reported an EPS of ₹0.346 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.509%.

Which hedge fund is a major shareholder of Medico Remedies Ltd.?

Currently, no hedge funds are holding shares in IN:MEDICO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medico Remedies Ltd.

Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.